• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Detection of macular ganglion cell complex loss and correlation with choroidal thickness in chronic and recurrent central serous chorioretinopathy.慢性复发性中心性浆液性脉络膜视网膜病变中黄斑神经节细胞复合体丢失的检测及其与脉络膜厚度的相关性
Int J Ophthalmol. 2023 Apr 18;16(4):579-588. doi: 10.18240/ijo.2023.04.12. eCollection 2023.
2
Ganglion Cell Loss in the Course of Central Serous Chorioretinopathy.中心性浆液性脉络膜视网膜病变病程中的神经节细胞丢失
Ophthalmol Ther. 2023 Feb;12(1):517-533. doi: 10.1007/s40123-022-00625-5. Epub 2022 Dec 12.
3
Continuous Eplerenone Treatment in Chronic Central Serous Chorioretinopathy: Long-Term Results from a Pilot Study.依普利酮持续治疗慢性中心性浆液性脉络膜视网膜病变:一项试点研究的长期结果
Clin Ophthalmol. 2023 Jul 17;17:2003-2012. doi: 10.2147/OPTH.S411094. eCollection 2023.
4
Evaluation of the effects of photodynamic therapy on chronic central serous chorioretinopathy based on the mean choroidal thickness and the lumen area of abnormal choroidal vessels.基于平均脉络膜厚度和异常脉络膜血管管腔面积评价光动力疗法对慢性中心性浆液性脉络膜视网膜病变的疗效。
Photodiagnosis Photodyn Ther. 2014 Dec;11(4):519-25. doi: 10.1016/j.pdpdt.2014.07.005. Epub 2014 Aug 4.
5
Chronic Central Serous Chorioretinopathy in Elderly Subjects: Structure and Blood Flow Characteristics of Retina and Choroid.老年慢性中心性浆液性脉络膜视网膜病变:视网膜和脉络膜的结构及血流特征
Ophthalmol Ther. 2024 Jan;13(1):321-335. doi: 10.1007/s40123-023-00849-z. Epub 2023 Nov 15.
6
CHOROIDAL VASCULARITY IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY AND ITS ASSOCIATION WITH RISK SINGLE-NUCLEOTIDE POLYMORPHISMS.慢性中心性浆液性脉络膜视网膜病变中的脉络膜血管性及其与风险单核苷酸多态性的关联
Retina. 2024 May 1;44(5):837-843. doi: 10.1097/IAE.0000000000004024. Epub 2024 Apr 18.
7
Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy.通过增强深度成像和扫频源光学相干断层扫描测量中心性浆液性脉络膜视网膜病变的脉络膜厚度
BMC Ophthalmol. 2014 Nov 25;14:145. doi: 10.1186/1471-2415-14-145.
8
Retinal and choroidal vasoreactivity in central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变的视网膜和脉络膜血管反应性。
Graefes Arch Clin Exp Ophthalmol. 2022 Dec;260(12):3825-3836. doi: 10.1007/s00417-022-05757-9. Epub 2022 Jul 15.
9
Clinical research on one-third dose verteporfin photodynamic therapy in the treatment of chronic central serous chorioretinopathy.三分之一剂量维替泊芬光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变的临床研究。
Eur Rev Med Pharmacol Sci. 2018 Jan;22(2):278-284. doi: 10.26355/eurrev_201801_14169.
10
RETROSPECTIVE ANALYSIS OF THE PRESENCE OF CHOROIDAL NEOVASCULARISATION USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY WITH THE AID OF PHOTODYNAMIC THERAPY.应用光相干断层扫描血管造影观察脉络膜新生血管在光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变中的作用
Cesk Slov Oftalmol. 2021 Winter;77(3):122-131. doi: 10.31348/2021/14.

引用本文的文献

1
Sleep and mood in central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变中的睡眠与情绪
Eye (Lond). 2025 Jun;39(8):1615-1623. doi: 10.1038/s41433-025-03688-3. Epub 2025 Feb 26.
2
Choroidal thickness measurements in young Saudi adult population: a cross-sectional study.沙特年轻成年人群脉络膜厚度测量:一项横断面研究。
Int J Ophthalmol. 2023 Nov 18;16(11):1814-1819. doi: 10.18240/ijo.2023.11.12. eCollection 2023.

本文引用的文献

1
Investigation of Serum and Macular Carotenoids in Central Serous Chorioretinopathy.中心性浆液性脉络膜视网膜病变患者血清及黄斑区类胡萝卜素的研究
Front Med (Lausanne). 2022 Apr 1;9:805305. doi: 10.3389/fmed.2022.805305. eCollection 2022.
2
Feature Detection by Retinal Ganglion Cells.视网膜神经节细胞的特征检测。
Annu Rev Vis Sci. 2022 Sep 15;8:135-169. doi: 10.1146/annurev-vision-100419-112009. Epub 2022 Apr 6.
3
Choroidal arteriovenous anastomoses: a hypothesis for the pathogenesis of central serous chorioretinopathy and other pachychoroid disease spectrum abnormalities.脉络膜动静脉吻合:中心性浆液性脉络膜视网膜病变及其他厚脉络膜疾病谱异常发病机制的一种假说
Acta Ophthalmol. 2022 Dec;100(8):946-959. doi: 10.1111/aos.15112. Epub 2022 Feb 18.
4
Changes in Plasma VEGF and PEDF Levels in Patients with Central Serous Chorioretinopathy.中心性浆液性脉络膜视网膜病变患者血浆血管内皮生长因子和色素上皮衍生因子水平的变化
Medicina (Kaunas). 2021 Oct 5;57(10):1063. doi: 10.3390/medicina57101063.
5
Pachychoroid disease and its association with retinal vein occlusion: a case-control study.脉络膜增厚性疾病及其与视网膜静脉阻塞的相关性:一项病例对照研究。
Sci Rep. 2021 Oct 6;11(1):19854. doi: 10.1038/s41598-021-99115-0.
6
Assessment of ganglion cell complex, macular thickness, and optic disc parameters in keratoconus patients.圆锥角膜患者神经节细胞复合体、黄斑厚度及视盘参数的评估
Saudi J Ophthalmol. 2021 Jul 29;34(4):256-260. doi: 10.4103/1319-4534.322604. eCollection 2020 Oct-Dec.
7
Central Serous Chorioretinopathy - an Overview.中心性浆液性脉络膜视网膜病变——概述。
Klin Monbl Augenheilkd. 2021 Sep;238(9):971-979. doi: 10.1055/a-1531-5605. Epub 2021 Aug 20.
8
Recent Advances and Disputes About Curcumin in Retinal Diseases.姜黄素在视网膜疾病中的最新进展与争议
Clin Ophthalmol. 2021 Jun 18;15:2553-2571. doi: 10.2147/OPTH.S306706. eCollection 2021.
9
Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders.静脉超负荷性脉络膜病变:中心性浆液性脉络膜视网膜病变及相关疾病的一个假说框架
Prog Retin Eye Res. 2022 Jan;86:100973. doi: 10.1016/j.preteyeres.2021.100973. Epub 2021 May 21.
10
Optical coherence tomography angiography in central serous chorioretinopathy: The current clinical role and future perspectives.光学相干断层扫描血管造影在中心性浆液性脉络膜视网膜病变中的应用:当前的临床作用和未来展望。
Surv Ophthalmol. 2022 Jan-Feb;67(1):68-82. doi: 10.1016/j.survophthal.2021.05.003. Epub 2021 May 14.

慢性复发性中心性浆液性脉络膜视网膜病变中黄斑神经节细胞复合体丢失的检测及其与脉络膜厚度的相关性

Detection of macular ganglion cell complex loss and correlation with choroidal thickness in chronic and recurrent central serous chorioretinopathy.

作者信息

Liu Yang-Chen, Wu Bin, Wang Yan, Chen Song

机构信息

Clinical College of Ophthalmology, Tianjin Medical University, Tianjin 300070, China.

Tianjin Eye Hospital, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin Eye Institute, Nankai University Affiliated Eye Hospital, Tianjin 300000, China.

出版信息

Int J Ophthalmol. 2023 Apr 18;16(4):579-588. doi: 10.18240/ijo.2023.04.12. eCollection 2023.

DOI:10.18240/ijo.2023.04.12
PMID:37077495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10089900/
Abstract

AIM

To investigate the association of ganglion cell complex thickness (GCCt), global loss volume percentage (GLV%), and focal loss volume percentage (FLV%) with structural and functional findings among patients with chronic central serous chorioretinopathy (CCSC) and recurrent central serous chorioretinopathy (RCSC) by optical coherence tomography (OCT).

METHODS

Among 29 patients with monocular affected central serous chorioretinopathy (CSC), 15 had CCSC, and 14 had RCSC. The GCCt, FLV%, GLV%, and subfoveal choroidal thickness (SFCT) and sublesional choroidal thickness (SLCT) values were determined using OCT, and the association of these characteristics with neural structure parameters, choroidal morphology, features and functional alterations were estimated for the CCSC and RCSC patients.

RESULTS

In CCSC, the affected eyes had significantly lower GCCt values than the fellow eyes in the macular regions (all <0.05), with the highest GCCt observed in the inferior area. A significant association was found between the GCCt in different regions and the change in best corrected visual acuity (BCVA; =-0.696; -0.695; -0.694, <0.05) in CCSC patients. A statistically significant moderate negative correlation indicated that long-term CCSC was associated with greater differences in the GCCt in different regions between affected and fellow eyes (=-0.562; =-0.556; =0.525, <0.05). Additionally, observation of thickened SFCT was associated with a worse FLV% (=0.599; =0.546, <0.05) in both groups. Similarly, thickened SLCT was associated with FLV% in RCSC patients (=0.544, <0.05).

CONCLUSION

The distribution and GCCt are associated with the duration and visual outcomes of CCSC, whereas there is no correlation among RCSC patients. FLV% may be instrumental in differentiating the various outer choroidal vessels (pachyvessels) in long-term CSC. These results suggest that neural structure parameters may aid in estimating and predicting the recovery of altered morphology and function in CCSC and RCSC patients.

摘要

目的

通过光学相干断层扫描(OCT)研究慢性中心性浆液性脉络膜视网膜病变(CCSC)和复发性中心性浆液性脉络膜视网膜病变(RCSC)患者的神经节细胞复合体厚度(GCCt)、整体损失体积百分比(GLV%)和局灶性损失体积百分比(FLV%)与结构和功能结果之间的关联。

方法

在29例单眼患中心性浆液性脉络膜视网膜病变(CSC)的患者中,15例为CCSC,14例为RCSC。使用OCT测定GCCt、FLV%、GLV%以及黄斑中心凹下脉络膜厚度(SFCT)和病变下脉络膜厚度(SLCT)值,并评估这些特征与CCSC和RCSC患者的神经结构参数、脉络膜形态、特征及功能改变之间的关联。

结果

在CCSC中,患眼黄斑区的GCCt值显著低于对侧眼(均<0.05),在下象限观察到最高的GCCt。在CCSC患者中,不同区域的GCCt与最佳矫正视力(BCVA)的变化之间存在显著关联(=-0.696;=-0.695;=-0.694,<0.05)。具有统计学意义的中度负相关表明,长期CCSC与患眼和对侧眼不同区域GCCt的更大差异相关(=-0.562;=-0.556;=0.525,<0.05)。此外,两组中观察到SFCT增厚均与更差的FLV%相关(=0.599;=0.546,<0.05)。同样,RCSC患者中SLCT增厚与FLV%相关(=0.544,<0.05)。

结论

GCCt的分布和厚度与CCSC的病程和视力结果相关,而RCSC患者之间无相关性。FLV%可能有助于区分长期CSC中各种外层脉络膜血管(厚血管)。这些结果表明,神经结构参数可能有助于评估和预测CCSC和RCSC患者形态和功能改变的恢复情况。